An interventional study of Green tea and Placebo in Cardiometabolic Syndrome, sponsored by University of Central Lancashire. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-27.
Sponsored by University of Central Lancashire · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 55 studies in Metabolic Syndrome with a site in United Kingdom — 9 open to participants now, 10 under way, none of them phase 3. Metabolic Syndrome · United Kingdom.
Among the 55 studies in Metabolic Syndrome with a site in United Kingdom, this one is the 26th largest by planned enrollment of the 48 interventional ones that give a count, is one of 3 that started in 2025, is one of 40 with no phase, and was the 50th registered.
2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.
Browse Metabolic Syndrome studies →9 of the 55 studies in Metabolic Syndrome with a site in United Kingdom are open now. Recruiting first, the newest first:
University of Liverpool · Sites in United Kingdom
Ages 40+ · Healthy volunteers
University of Nottingham · Sites in United Kingdom
Ages 50–65 · Healthy volunteers
University of Central Lancashire · Sites in United Kingdom
Ages 18–65 · Healthy volunteers
Eclat Srl. · Sites in United Kingdom
Ages 23+
Salah Snouda · Sites in United Kingdom
Ages 18+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
55 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 3 · Phase 4 2
First in 2005; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 60 across 1,574 interventional studies indexed under Metabolic Syndrome.
Median enrollment 45 across the 48 interventional studies, 100 across the 7 observational. Of the 40 that completed or were terminated, 4 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 55 have an industry lead sponsor. The 10 most frequent:
University of Central Lancashire is the lead sponsor of 31 studies on the registry; 10 are open to participants now.
University of Central Lancashire has 7 studies filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
5 of the studies in Metabolic Syndrome with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07606872Salah SnoudaValidation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes | 2026-12 |
| NCT06795438University of Central LancashireEffects of Green Tea on Cardiometabolic Outcomes | 2027-02-01 |
| NCT07474233Liverpool John Moores UniversityAssociations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health | 2027-05 |
| NCT07462871Liverpool John Moores UniversityComparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health | 2027-06 |
| NCT06784154University of LiverpoolThe Role of Ectopic Fat and Heart Attack Risk in HIV | 2027-06-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 55 studies in Metabolic Syndrome with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Green tea may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Green tea tablets 1000mg 1 x per day
Dietary Supplement: Green tea
Placebo control 1 x blinded placebo tablet per day
Other: Placebo
Green tea tablets 1000mg 1 x per day
Placebo control 1 x blinded placebo tablet per day
Systolic blood pressure
Systolic blood pressure - measured using a digital blood pressure monitor
Time frame: Baseline
Systolic blood pressure
Systolic blood pressure - measured using a digital blood pressure monitor
Time frame: 20 days
Diastolic blood pressure
Diastolic blood pressure - measured using a digital blood pressure monitor
Time frame: Baseline
Diastolic blood pressure
Diastolic blood pressure - measured using a digital blood pressure monitor
Time frame: 20 days
Percent bodyfat
Participants percentage composition of fat - measured using bio-electrical impedance
Time frame: Baseline
Percent bodyfat
Participants percentage composition of fat - measured using bio-electrical impedance
Time frame: 20 days
Waist to hip ratio
Ratio of waist to hip circumference - measured using anthropocentric tape
Time frame: Baseline
Waist to hip ratio
Ratio of waist to hip circumference - measured using anthropocentric tape
Time frame: 20 days
Blood glucose
Capillary blood glucose - mmol/L
Time frame: Baseline
Blood glucose
Capillary blood glucose - mmol/L
Time frame: 20 days
Blood triglycerides
Capillary blood triglycerides - mmol/L
Time frame: Baseline
Blood triglycerides
Capillary blood triglycerides - mmol/L
Time frame: 20 days
Triglyceride glucose index
Calculated as the natural logarithm of (blood triglycerides x blood glucose) /2)
Time frame: Baseline
Triglyceride glucose index
Calculated as the natural logarithm of (blood triglycerides x blood glucose) /2)
Time frame: 20 days
Blood cholesterol (Total, HDL & LDL)
Capillary blood cholesterol - mmol/L
Time frame: Baseline
Blood cholesterol (Total, HDL & LDL)
Capillary blood cholesterol - mmol/L
Time frame: 20 days
Coop-Wonka chart
Psychological wellbeing - The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring
Time frame: Baseline
Coop-Wonka chart
Psychological wellbeing - The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring
Time frame: 20 days
Beck Depression Inventory
sychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.
Time frame: Baseline
Beck Depression Inventory
sychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.
Time frame: 20 days
State Trait Anxiety Inventory
Psychological wellbeing - the state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.
Time frame: Baseline
State Trait Anxiety Inventory
Psychological wellbeing - the state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.
Time frame: 20 days
Insomnia Severity Index
Sleep quality - The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.
Time frame: Baseline
Insomnia Severity Index
Sleep quality - The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.
Time frame: 20 days
Pittsburgh Sleep Quality Index
Sleep quality - The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.
Time frame: Baseline
Pittsburgh Sleep Quality Index
Sleep quality - The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.
Time frame: 20 days
Epworth Sleepiness Scale
Sleep quality - The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.
Time frame: Baseline
Epworth Sleepiness Scale
Sleep quality - The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.
Time frame: 20 days
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Apr 2025; primary completion for Feb 2027, 22 months later.
Of 627 non-industry interventional studies with no phase under Metabolic Syndrome, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's planned 22 months is close to that.
Counting every sponsor, half of 677 studies reached it within 20 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tea
University of Central Lancashire